Algeron Uses, Dosage, Side Effects and more
Algeron is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C).
| Trade Name | Algeron |
| Generic | Cepeginterferon alfa-2B |
| Cepeginterferon alfa-2B Other Names | Algeron, Cepeginterferon Alfa 2 B, Cepeginterferon alfa-2B, Pegylated human interferon A-2B |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
